Thu, Oct 27, 2016
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Estimize announces data licensing agreement with Bloomberg

Thursday, April 18, 2013

Bailey McCann, Opalesque New York: Estimize, the buy side and independent analyst earnings estimates platform, today announced a licensing agreement with Bloomberg to feature Estimize’s earnings data on more than 900 publicly traded stocks via the Bloomberg Professional service’s news and research feeds. Opalesque recently interviewed Estimize CEO, Leigh Drogen about the company which seeks to open up earnings estimates and provide analysis not driven by sell-side incentives.

Estimize claims that its estimates are 67% more accurate than their sell-side cohorts. The company said in a statement today that the agreement with Bloomberg further validates this claim. The accuracy is driven by the diverse range of analysts contributing on Estimize, comprised of hedge fund, institutional buy-side, independent research and individual investors. Drogen, himself, was a former hedge fund quantitative analyst, and wants to improve upon the inherently conflicted estimates produced by the sell-side.

"The Bloomberg community consists of more than 300,000 financial professionals and we’re thrilled to be a part of that community as a data provider. In addition to validating the philosophy behind our process and accuracy of our earnings data, we believe the licensing agreement with Bloomberg will help drive an amazing set of new contributors to our platform, furth......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. David Einhorn speaks on passive investing, Mylan, his cheapest stock, the Fed[more]

    From Greenlight Capital hedge fund manager David Einhorn (Trades, Portfolio) joined nine other famed investors on Tuesday to talk about stocks at the annual Great Investors’ Best Ideas Investment Symposium in Dallas. Presenters at the annual conference typically pitch one or severa

  2. Investing - Fund set up to buy illiquid hedge fund stakes finds plenty of opportunities, Lansdowne's Roden says likes animal genetics company Genus[more]

    Fund set up to buy illiquid hedge fund stakes finds plenty of opportunities From As ValueWalk reported back in February, earlier this year Andrew Lawrence set out to raise $250 million to $500 million for a fund that will buy stakes in hedge funds that have suspended redem

  3. Opalesque Roundtable: Style drift, poor communications and credibility fatigue are biggest red flags for hedge funds investors[more]

    Komfie Manalo, Opalesque Asia: Style drift, poor communications and credibility fatigue are the biggest red flags for hedge funds investors, said participants of the latest 2016 Opalesque Investor Roundtable, sponso

  4. Barclay CTA Index down 0.40% in September (+0.10% YTD)[more]

    Managed futures traders lost 0.40% in September according to the Barclay CTA Index compiled by BarclayHedge. The Index is up 0.10% year to date. “The US Fed, in spite of its hawkish tone, opted to hold rates steady which roiled financial markets,” says Sol Waksman, founder and president of BarclayHe

  5. Opalesque Exclusive: Meet Emma, your friendly A.I. helper[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Shaunka Khire, who co-designed an artificial intelligence (AI) robot called EMMA/MANSI, talks to Opalesque